AU2002344208A8 - Molecules for diagnostics and therapeutics - Google Patents

Molecules for diagnostics and therapeutics

Info

Publication number
AU2002344208A8
AU2002344208A8 AU2002344208A AU2002344208A AU2002344208A8 AU 2002344208 A8 AU2002344208 A8 AU 2002344208A8 AU 2002344208 A AU2002344208 A AU 2002344208A AU 2002344208 A AU2002344208 A AU 2002344208A AU 2002344208 A8 AU2002344208 A8 AU 2002344208A8
Authority
AU
Australia
Prior art keywords
therapeutics
diagnostics
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002344208A
Other versions
AU2002344208A1 (en
Inventor
Bernard Harris
Gerard E Dufour
Anissa Lee Jones
Vincent Z Mullahy-Flores
Jennifer L Jackson
Abel Daffo
Edward Jr H Gerstin
Alice J Chen
Ruth Y Lan
Jimmy Y Yu
Tam C Dam
Yael Kleefeld
Joyce Chinn
Audrey Lo
Careyna H Peralta
Alanna-Phung B Tran
Marie H David
Michael E Urashka
Tommy F Liu
Samantha A Lewis
Stefan R Amshey
Christopher R Dahl
Pierre E Yap
Darryl Gietzen
Rakesh Marwaha
Olivia Tuason
Scott R Panzer
Sean C Daughtery
Duy-Viet An Nguyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002344208A1 publication Critical patent/AU2002344208A1/en
Publication of AU2002344208A8 publication Critical patent/AU2002344208A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002344208A 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics Abandoned AU2002344208A1 (en)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US27961901P 2001-03-28 2001-03-28
US60/279,619 2001-03-28
US28006801P 2001-03-29 2001-03-29
US28006701P 2001-03-29 2001-03-29
US60,280,068 2001-03-29
US60/280,067 2001-03-29
US29128001P 2001-05-16 2001-05-16
US60/291,280 2001-05-16
US29182901P 2001-05-17 2001-05-17
US29184901P 2001-05-17 2001-05-17
US60,291,829 2001-05-17
US60/291,849 2001-05-17
US29942801P 2001-06-19 2001-06-19
US60,299,428 2001-06-19
US29977601P 2001-06-20 2001-06-20
US30000101P 2001-06-20 2001-06-20
US60/300,001 2001-06-20
US60/299,776 2001-06-20
PCT/US2002/010056 WO2002097031A2 (en) 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics

Publications (2)

Publication Number Publication Date
AU2002344208A1 AU2002344208A1 (en) 2002-12-09
AU2002344208A8 true AU2002344208A8 (en) 2005-11-17

Family

ID=27578771

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002338265A Abandoned AU2002338265A1 (en) 2001-03-28 2002-03-27 Molecules for disease detection and treatment
AU2002344208A Abandoned AU2002344208A1 (en) 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2002338265A Abandoned AU2002338265A1 (en) 2001-03-28 2002-03-27 Molecules for disease detection and treatment

Country Status (4)

Country Link
EP (1) EP1383894A2 (en)
AU (2) AU2002338265A1 (en)
CA (2) CA2442705A1 (en)
WO (2) WO2002079449A2 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
WO2002074906A2 (en) * 2001-03-16 2002-09-26 Eli Lilly And Company Lp mammalian proteins; related reagents
ATE364690T1 (en) * 2001-11-09 2007-07-15 Proteologics Inc POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS
US8753822B2 (en) * 2001-12-04 2014-06-17 Wayne State University Neoepitope detection of disease using protein arrays
AU2003228084A1 (en) * 2002-05-28 2003-12-12 Omrix Biopharmaceuticals Inc. Method for obtaining anti-idiotype antibodies
CA2488382A1 (en) 2002-06-05 2003-12-18 Case Western Reserve University Methods and compositions for detecting cancers
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
TW200418988A (en) * 2002-09-30 2004-10-01 Oncotherapy Science Inc Method for diagnosing prostate cancer
AU2003271149A1 (en) * 2002-10-11 2004-05-04 Yamanouchi Pharmaceutical Co., Ltd. Method of screening remedy for renal failure
EP2314676A1 (en) * 2002-11-26 2011-04-27 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP1589110A4 (en) * 2002-12-27 2006-06-07 Nat Inst Of Advanced Ind Scien Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
GB0315827D0 (en) * 2003-07-05 2003-08-13 Imp College Innovations Ltd Methods
US20080274975A1 (en) * 2004-04-12 2008-11-06 The Trustees Of Columbia University In The City Of New Yourk Methods and Compositions for Inhibiting Abad/Abeta Protein Interaction
EP1627922A1 (en) * 2004-08-18 2006-02-22 Sanofi-Aventis Deutschland GmbH Method of screening for a carnitine transporter agonist or antagonist and its uses
GB0423126D0 (en) * 2004-10-18 2004-11-17 Ares Trading Sa Protein
US7727725B2 (en) 2006-04-27 2010-06-01 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
US8652472B2 (en) 2006-12-05 2014-02-18 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
US20110250218A1 (en) * 2008-10-29 2011-10-13 Fong Lawrence H Disease-Associated Antigens and Methods of Use Thereof
US9175353B2 (en) 2008-11-14 2015-11-03 Gen-Probe Incorporated Compositions, kits and methods for detection of campylobacter nucleic acid
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
EP2552947A4 (en) 2010-03-26 2013-11-13 Dartmouth College Vista regulatory t cell mediator protein, vista binding agents and use thereof
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
CA2810928A1 (en) 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
CN104321333A (en) 2012-03-21 2015-01-28 沃泰克斯药物股份有限公司 Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
AU2013312211B2 (en) 2012-09-07 2018-03-29 King's College London VISTA modulators for diagnosis and treatment of cancer
WO2015097536A2 (en) 2013-12-24 2015-07-02 Janssen Pharmaceutical Nv Anti-vista antibodies and fragments
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
AU2015274504B2 (en) 2014-06-11 2021-02-04 Kathy A. Green Use of VISTA agonists and antagonists to suppress or enhance humoral immunity
AU2015357463B2 (en) 2014-12-05 2021-10-07 Immunext, Inc. Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
BR112017027870A2 (en) 2015-06-24 2018-08-28 Janssen Pharmaceutica Nv antibodies and anti-sight fragments
US10899836B2 (en) 2016-02-12 2021-01-26 Janssen Pharmaceutica Nv Method of identifying anti-VISTA antibodies
CA3020848A1 (en) 2016-04-15 2017-10-19 Janssen Pharmaceuticals, Inc. Anti-human vista antibodies and use thereof
US20210223232A1 (en) * 2018-06-26 2021-07-22 Duke University Synthetic odorant receptors
CN110714017B (en) * 2019-11-06 2023-09-01 河南师范大学 Koi ptps gene, coded protein and application
CN111621525B (en) * 2020-06-18 2021-04-23 中赛干细胞基因工程有限公司 Application of STX1B gene in promoting growth and differentiation of human adipose-derived mesenchymal stem cells
CN114317732B (en) * 2021-04-08 2023-08-18 博尔诚（北京）科技有限公司 Composition for lung cancer screening and application thereof

Also Published As

Publication number Publication date
WO2002079449A3 (en) 2003-03-20
WO2002097031A2 (en) 2002-12-05
AU2002344208A1 (en) 2002-12-09
WO2002097031A3 (en) 2005-05-12
CA2447183A1 (en) 2002-10-10
EP1383894A2 (en) 2004-01-28
WO2002079449A2 (en) 2002-10-10
CA2442705A1 (en) 2002-12-05
AU2002338265A1 (en) 2002-10-15

Similar Documents

Publication Publication Date Title
AU2002344208A8 (en) Molecules for diagnostics and therapeutics
AU2003289716A8 (en) Molecules for diagnostics and therapeutics
AU3662101A (en) Cd40-binding apc-activating molecules
EP1423120A4 (en) 2h-phthalazin-1-ones and methods for use thereof
TW531019U (en) Improved LCD seat
EP1552002A4 (en) Aptamer-toxin molecules and methods for using same
AU5720601A (en) Bispecific molecules and uses thereof
AU2002325755A1 (en) Methods and apparatuses for purification
EP1520032A4 (en) Lung cancer therapeutics and diagnostics
DE60210581D1 (en) Substituierte carbostyrilderivate als 5-ht1a-subtyp agonisten
EP1434772A4 (en) Compounds and methods
GB0106099D0 (en) Carriages
AU2002359694A8 (en) Compounds and methods
AU2003210518A1 (en) Molecules for diagnostics and therapeutics
GB2378440B (en) Acridine based molecules and processes for the preparation thereof
EP1379240A4 (en) Compounds and methods
GB0022670D0 (en) Molecules
AU8696401A (en) Molecules for diagnostics and therapeutics
AU4175401A (en) Molecules for diagnostics and therapeutics
AU2002305913A1 (en) Molecules for diagnostics and therapeutics
GB0002625D0 (en) Dendroaspin molecules
AU2001241754A1 (en) Molecules for diagnostics and therapeutics
AU2001286964A1 (en) Molecules for diagnostics and therapeutics
HUP0202901A2 (en) Modified based metathese-catalyzers
GB0113923D0 (en) Therapeutics

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase